Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield

Vaccine

Volumn 28, Issue 43, 2010, Pages 6951-6957

  Chung, Cheng Yu ^a   Chen, Chi Yuan ^a   Lin, Shih Yeh ^a   Chung, Yao Chi ^a   Chiu, Hsin Yi ^a   Chi, Wei Kuang ^b   Lin, Yu Li ^c   Chiang, Bor Luen ^d   Chen, Wei Jheng ^a   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

3CD protease; Baculovirus; Bioprocess; Enterovirus 71; Virus like particles

Indexed keywords

ENTEROVIRUS 71 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BIOREACTOR; CELL CULTURE; CELL DENSITY; CONTROLLED STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS CHARACTERIZATION; VIRUS LIKE AGENT; VIRUS PARTICLE; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; BIOREACTORS; CELL COUNT; CELL CULTURE TECHNIQUES; CELL LINE; ENTEROVIRUS A, HUMAN; FEMALE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SPODOPTERA; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES; VIRUS CULTIVATION;

EID: 77957350005     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.052     Document Type: Article

References (36)

1. McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002, 26:91-107.
2. Brown B.A., Oberste M.S., Alexander J.P., Kennett M.L., Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 1999, 73:9969-9975.
3. Tee K.K., Lam T.T.Y., Chan Y.F., Bible J.M., Kamarulzaman A., Tong C.Y.W., et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol 2010, 84:3339-3350.
4. Lin T.Y., Twu S.J., Ho M.S., Chang L.Y., Lee C.Y. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis 2003, 9:291-293.
5. Ong K.C., Devi S., Cardosa M.J., Wong K.T. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 2010, 84:661-665.
6. Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2002, 20:895-904.
7. Lin Y.C., Wu C.N., Shih S.R., Ho M.S. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine 2002, 20:2485-2493.
8. Arita M., Nagata N., Iwata N., Ami Y., Suzaki Y., Mizuta K., et al. An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol 2007, 81:9386-9395.
9. Shih S.R., Li Y.S., Chiou C.C., Suen P.C., Lin T.Y., Chang L.Y., et al. Expression of caspid protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection. J Med Virol 2000, 61:228-234.
10. Chen H.F., Chang M.H., Chiang B.L., Jeng S.T. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 2006, 24:2944-2951.
11. Chen H.L., Huang J.Y., Chu T.W., Tsai T.C., Hung C.M., Lin C.C., et al. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 2008, 26:2882-2889.
12. Lee M.S., Chang L.Y. Development of enterovirus 71 vaccines. Expert Rev Vaccines 2010, 9:149-156.
13. Mateu M.G. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res 1995, 38:1-24.
14. Noad R., Roy P. Virus-like particles as immunogens. Trends Microbiol 2003, 11:438-444.
15. Ramqvist T., Andreasson K., Dalianis T. Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer. Expert Opin Biol Ther 2007, 7:997-1007.
16. Hu Y.-C. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 2005, 26:405-416.
17. Hu Y.-C., Hsu T.-A., Huang J.-H., Ho M.-S., Ho Y.-C. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol Lett 2003, 25:919-925.
18. Chung Y.-C., Huang J.-H., Lai C.-W., Sheng H.-C., Shih S.-R., Ho M.-S., et al. Expression, purification and characterization of enterovirus 71 virus-like particles. World J Gastroenterol 2006, 12:921-927.
19. Chung Y.-C., Ho M.-S., Wu J.-C., Chen W.-J., Huang J.-H., Chou S.-T., et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
20. Hu Y.-C., Tsai C.-T., Chang Y.-J., Huang J.-H. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog 2003, 19:373-379.
21. Jarvis D.L., Fleming J., Kovacs G.R., Summers M.D., Guarino L.A. Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells. Bio-Technology 1990, 8:950-955.
22. Krammer F., Schinko T., Palmberger D., Tauer C., Messner P., Grabherr R. Trichoplusia ni cells (High Five™) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol 2010, 45:226-234.
23. Ikonomou L., Schneider Y.-J., Agathos S.N. Insect cell culture for industrial production of recombinant proteins. Appl Microbiol Biotechnol 2003, 62:1-20.
24. Maranga L., Cruz P.E., Aunins J.G., Carrondo M.J. Production of core and virus-like particles with baculovirus infected insect cells. Adv Biochem Eng Biotechnol 2002, 74:183-206.
25. Hu Y.-C., Bentley W.E. Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: deterministic predictions and experimental results. Biotechnol Bioeng 2001, 75:104-119.
26. Cruz P.E., Cunha A., Peixoto C.C. Optimization of the production of virus-like particles in insect cells. Biotechnol Bioeng 1998, 60:408-418.
27. Aucoin M.G., Mena J.A., Kamen A.A. Bioprocessing of baculovirus vectors: a review. Curr Gene Ther 2010, 10:174-186.
28. Sander L., Harrysson A. Using cell size kinetics to determine optimal harvest time for Spodoptera frugiperda and Trichoplusia ni BTI-TN-5B1-4 cells infected with a baculovirus expression vector system expressing enhanced green fluorescent protein. Cytotechnology 2008, 54:35-48.
29. Hancock K., Narang S., Pattabhi S., Yushak M.L., Khan A., Lin S.C., et al. False positive reactivity of recombinant, diagnostic, glycoproteins produced in High Five insect cells: effect of glycosylation. J Immunol Methods 2008, 330:130-136.
30. Colin G.H., James J.V., William E.B. In vitro and in vivo RNA interference mediated suppression of Tn-caspase-1 for improved recombinant protein production in High Five™ cell culture with the baculovirus expression vector system. Biotechnol Bioeng 2009, 104:390-399.
31. Carinhas N., Bernal V., Monteiro F., Carrondo M.J.T., Oliveira R., Alves P.M. Improving baculovirus production at high cell density through manipulation of energy metabolism. Metab Eng 2010, 12:39-52.
32. Muir P., Kammerer U., Korn K., Mulders M.N., Poyry T., Weissbrich B., et al. Molecular typing of enteroviruses: current status and future requirements. Clin Microbiol Rev 1998, 11:202-227.
33. Mizuta K., Aoki Y., Suto A., Ootani K., Katsushima N., Itagaki T., et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata Japan, between 1990 and 2007. Vaccine 2009, 27:3153-3158.
34. Huang Y.-P., Lin T.-L., Kuo C.-Y., Lin M.-W., Yao C.-Y., Liao H.-W., et al. The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res 2008, 137:206-212.
35. Huang S.W., Hsu Y.W., Smith D.J., Kiang D., Tsai H.P., Lin K.H., et al. Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol 2009, 47:3653-3662.
36. Ding N.Z., Wang X.M., Sun S.W., Song Q., Li S.N., He C.Q. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Res 2009, 145:157-161.